Cris “Cyborg” Granted Therapeutic Use Exemption by USADA
By FCF Staff
Cris “Cyborg” Justino has been granted a Therapeutic Use Exemption by USADA, clearing the way for the featherweight star to fight in the coming weeks.
Since it was announced that Justino had tested positive for a diuretic in December, the Brazilian fighter has said she was prescribed the substance by her physicians. Justino reported the treatment was for the physical abuse she incurred cutting to 140 pounds for catchweight fights.
On Friday, USADA released a lengthy statement, announcing that Justino’s provisional suspension has been lifted as a result of the TUE. Here is an excerpt from the statement:
USADA announced today that UFC® athlete Cristiane Justino, of Curitiba, Brazil, has been granted a retroactive Therapeutic Use Exemption (TUE) and will therefore not face an anti-doping policy violation after testing positive for a prohibited substance in December of 2016.
Justino, 31, tested positive for Spironolactone, following an out-of-competition urine test conducted on December 5, 2016. Spironolactone is a prohibited substance in the category of Diuretics and Masking Agents and is prohibited at all times under the UFC Anti-Doping Policy, which has adopted the World Anti-Doping Agency (WADA) Prohibited List.
Upon notice of her positive test, Justino immediately identified a medication prescribed by her physician for the treatment of a common endocrine disorder as the source of the prohibited substance detected in her sample. She also participated in multiple interviews with USADA’s investigative team and consented to USADA interviewing her physician as well.
After a thorough investigation of the circumstances that preceded her positive test, which included a comprehensive review of Justino’s documented medical history, USADA accepted Justino’s explanation that her use of Spironolactone began in late September, following her bout at UFC Fight Night Brasilia, and was in accordance with her physician’s recommendation for the treatment of a legitimate medical condition. Nonetheless, because Spironolactone is prohibited at all times under the UFC Anti-Doping Policy, USADA advised Justino that her use of the medication without a valid TUE violated the UFC Anti-Doping Policy. Accordingly, Justino applied for a TUE to authorize her use of the medication, with retroactive effect.